PDF-Chronic Myeloid Leukaemia CMLA guide for patients families and whan

The Leukaemia Blood Foundation gratefully acknowledges Novartis Oncology for their contribution to the production of this booklet CONTENTSPAGEIntroductionThe Leukaemia Blood FoundationBone marrow. Three-stepimagerecticationPascalMONASSE1monasse@imagine.enpc.frJean-MichelMOREL2morel@cmla.ens-cachan.frZhongweiTANG2tang@cmla.ens-cachan.fr1IMAGINE,LIGM/Universit MPD. Myeloproliferative. . neoplasms. (MPN) constitute one of five categories of myeloid malignancies, according to the World Health Organization (WHO) classification system for hematopoietic . tumors. BMJ Learning. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Asthma. Jackie Thomson. LYMPHOID. MYELOID. ACUTE / IMMATURE. MATURE/ . CHRONIC. LYMPHOID. MYELOID. MATURE. IMMATURE. B-ALL. T-ALL. LYMPHOID. MYELOID. MATURE. IMMATURE. B-ALL. T-ALL. AML. MDS. LYMPHOID. MYELOID. . د.ميسم. مؤيد علوش . LEC.1. The white blood cells (leucocytes) may be divided into . two. . broad groups: the . phagocytes and the lymphocytes.. Phagocytes can themselves be subdivided into: . Ass.Prof.Abeer. . Anwer. Ahmed. The . leukaemias. are a group of disorders characterized by . the accumulation . of malignant white cells in the bone marrow and. blood. . These . abnormal cells cause symptoms because of: . Dr.Maysem. . Mouayad. . Alwash. . LEC.3. Objectives:. 1-Define CLL . 2-Enumerate the clinical features of CLL. 3-Describe the laboratory diagnosis of CLL. 4-Know the staging system and prognostic factors. Justyna Rybka. Department of . Haematology. , Blood Neoplasms and Bone Marrow Transplantation. Wroclaw Medical University. Klinika Hematologii, Nowotworów Krwi. i Transplantacji Szpiku . AML is a heterogeneous haematological malignancy of the myeloid blood cells. BSW00073 / OK 11 - ONC - 152 1 July , 2011 Fact Sheet Leukemia is a cancer that begins in the bone marrow ( the soft inner part of some bones), but in most cases, moves into the blood. It can t hen s C76.4 Upper limb C76.5 Lower limb C76.7 Other ill-defined sites C76.8 Overlapping lesion of other and ill-defined sites C77.0 Lymph nodes of head, face and neck Supraclavicular lymph nodes C77.1 A Guide for Being diagnosed with acute myeloid leukaemia (AML) can be a shock, particularly when you may never have heard of it. If you have questions about AML – what causes it, who it affects, Use of these materials. You are free to use these initial versions of these materials for educational and quality improvement purposes. You may not use the material for commercial purposes. . So that we may track the use and implementation of these materials, and iteratively improve them, we respectfully request that upon use, you notify the Roadmap Project at . Joanne Aitken, Danny Youlden, Cate Brown, Andy Moore. Cancer Council Queensland. Queensland Children’s Hospital. Background. t-AML occurs in patients exposed to cytotoxic chemotherapy and/or radiotherapy . CONSULTANT HAEMATOLOGIST . HEAD OF HAEMATOLOGY DIVISION. DEPARTMENT OF PATHOLOGY. Heterogeneous group of hematopoietic . neoplasms. Uncontrolled . proliferation and . decreased apoptotic . activity with variable degrees of differentiation .